Health tech deals
BioNTech has closed its acquisition of CureVac, ending the subsequent offering period and setting up a push to expand mRNA design, delivery and manufacturing. The subsequent offering period expired at 12:01am Eastern Time on 18 December 2025, the company said. BioNTech said 195,341,219 CureVac shares, about 86.75 per cent of those issued and outstanding, were [...]
VYNE and Yarrow agreed a merger to form Yarrow Bioscience and advance YB-101, a TSH receptor antibody for Graves’ and thyroid eye disease. The all-stock deal will see the combined company operate as Yarrow Bioscience and list on Nasdaq under YARW, subject to approvals. Closing is targeted for the second quarter of 2026. Pre-closing financings [...]
Lucis has announced it has closed a US$8.5 million seed funding round led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures. The funding will enable the startup to accelerate its rollout in France, the UK, Ireland and Portugal, as well as in new markets, expand its [...]
SRx Health agreed the acquisition of EMJX, pivoting from healthcare to a digital asset platform; Eric M. Jackson will be chief executive and chair on closing. SRx Health Solutions said it has a definitive agreement to acquire EMJ Crypto Technologies (EMJX). The deal marks a shift from healthcare to building a digital asset treasury platform, [...]
Healthcare Triangle signed an advance agreement to acquire Teyame AI’s Spain-incorporated companies, Teyame 360 and Datono Mediacion, in a planned US$50m deal closing in Q1 2026. The consideration will include cash, common stock, non-voting convertible preferred stock and contingent earnout-based equity. The acquired assets are expected to generate approximately US$34m in incremental annual revenue and [...]
London-based startup Punto Health has raised €2.3m in seed funding to scale its AI dementia care platform across the UK and Spain. The seed round was co-led by Shilling VC and Plus Partners, with participation from Exceptional Ventures, Heartfelt, Fondo Bolsa Social and ABAC Nest. Punto Health says the investment will accelerate product development and [...]
Fertility startup Inito has raised US$29m in Series B to scale its at-home diagnostics platform and develop AI-designed antibodies. The funding round was led by Bertelsmann India Investments and Fireside Ventures, bringing Inito's total funding to around US$45m. The company previously raised US$6m led by Fireside Ventures and US$9m from Y Combinator, former Nurx chief [...]
Hims & Hers Health will acquire Boston-based YourBio Health, a microneedle blood sampling firm. YourBio's TAP device uses bladeless microneedles to collect capillary blood in seconds with minimal discomfort. Microneedles are tiny, short needles that draw small samples without a full venous draw. The transaction is expected to close in early 2026, subject to customary [...]
Paris-based obesity care startup Annette has raised €2m to expand clinical support for patients using GLP-1 weight-loss treatments. GLP-1 medicines, such as Wegovy and Mounjaro, reduce appetite; Annette says weight can return without supervision, nutrition guidance and emotional support. The funding will enable Annette to scale its model to tens of thousands of patients in [...]
Magentus, a provider of intelligent healthcare technology across the UK and Australia, has announced the acquisition of Labflow, a modern, cloud-native suite of pathology software products. This strategic move expands Magentus’s global footprint and strengthens its position as a leader in connected, scalable healthcare solutions. The acquisition will enhance Evolution vLab, Magentus’ enterprise-grade Laboratory Information [...]
